Determinants of high sessile serrated lesion detection: Role of faecal occult blood test and colonoscopy quality indicators

Table 5 Polypectomy and detection rates by indication

Indication	Proportions (%)
	Polypectomy rate	ADR	ASLDR	PSDR	SPDR	SSL-DR
Overall (n = 1450)	83.66	57.03	48	37.1	30.97	30.69
Clinical symptoms (n = 419)	75.1	51.31	39.38	29.83	24.34	24.34
FOBT (+) (n = 100)	90	81	58	43	43	42
Surveillance (previous patient) (n = 792)	86.49	56.19	49.62	38.64	31.94	31.69
Surveillance (new patient) (n = 74)	87.84	63.51	55.41	45.95	39.19	39.19
Screening (n = 65)	89.23	60	60	46.15	33.85	32.31

FOBT (+): Faecal occult blood test positive; Polypectomy rate: The proportion of colonoscopies during which at least one polypectomy was performed; ADR: Adenoma detection rate; ASLDR: Any serrated lesion detection rate; SPDR: Serrated polyp detection rate; PSDR: Proximal serrated detection rate; SSL-DR: Sessile serrated lesion detection rate.